Centrient Pharmaceuticals India Private Limited
⚠️ Moderate Risk
FEI: 3004497364 • Nawashahr, Punjab • INDIA
FEI Number
3004497364
Location
Nawashahr, Punjab
Country
INDIAAddress
Bhai Mohan Singh Nagar, Village Toansa, District Sbs Nagar, Nawashahr, Punjab, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/23/2022 | 61JCG16ROSUVASTATIN CALCIUM | Division of Southeast Imports (DSEI) | |
| 11/23/2022 | 61JCG16ROSUVASTATIN CALCIUM | Division of Southeast Imports (DSEI) | |
| 1/4/2011 | 56BYY03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Centrient Pharmaceuticals India Private Limited's FDA import refusal history?
Centrient Pharmaceuticals India Private Limited (FEI: 3004497364) has 3 FDA import refusal record(s) in our database, spanning from 1/4/2011 to 11/23/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Centrient Pharmaceuticals India Private Limited's FEI number is 3004497364.
What types of violations has Centrient Pharmaceuticals India Private Limited received?
Centrient Pharmaceuticals India Private Limited has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Centrient Pharmaceuticals India Private Limited come from?
All FDA import refusal data for Centrient Pharmaceuticals India Private Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.